Trials / Completed
CompletedNCT01958411
Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (actual)
- Sponsor
- Korea University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
* Vascular inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising tool for identifying and quantifying vascular inflammation within atherosclerotic plaques. * Non-alcoholic fatty liver disease (NAFLD) is closely associated with many cardiometabolic risk factors. NAFLD can be detected by measuring liver fat accumulation using computed tomography (CT). * Also epicardial adipose tissue (EAT) volume as determined by computed tomography (CT) is an independent marker of cardiovascular events in the general population. * Therefore, the purpose of this investigators study is to compare the NAFLD severity and EAT volume with FDG uptake measured by PET/CT.
Conditions
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2011-03-01
- First posted
- 2013-10-09
- Last updated
- 2013-10-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01958411. Inclusion in this directory is not an endorsement.